MedPage Today: Promising results for living donor transplants
UC expert says patient selection key for treatment of colorectal cancer liver metastases
A new prospective study found select patients with unresectable colorectal cancer liver metastases (CRLM) had good survival outcomes following a living-donor liver transplant.
Shimul Shah, MD, professor and division chief of transplantation, vice chair for Health Services Research and James and Catherine Orr Endowed Chair of liver transplantation in the University of Cincinnati College of Medicine's Division of Surgery, and Parsia Vagefi, MD, of the University of Texas Southwestern Medical Center, published an editorial in JAMA accompanying the study research. While the study is encouraging, the duo said it is important to select the proper patients for this type of procedure.
"It is imperative to better understand favorable tumor biology that goes beyond a perceived response to systemic and local therapies, because we are missing the mark if favorable tumor biology leads to recurrence within six months after transplant," Shah and Vagefi said. "We must carefully consider the use of living liver donors for this indication, given not only the current uncertainties in management of CRLM but also the growing number and availability of deceased donors and technologies such as machine perfusion, which will allow the broader sharing of marginal organs."
Read the MedPage Today article.
Featured photo at top of Shimul Shah, MD, in surgery.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.